文献速递复苏、休克与脓毒症心脑血管急症重症综合管理与镇静镇痛

如何在医疗政策中确定急诊医疗的重点:可治疗死亡概念的提出

How to determine the focus of emergent medical care in healthcare policy: Proposal of treatable death.
PubMed 文献 · Am J Emerg Med · 2024-05-30
一句话结论基于韩国国家急诊科信息系统数据构建分阶段可治疗死亡模型,建议将更多医疗资源重新分配给脓毒症而非急性心肌梗死或卒中。

本研究提出用可治疗死亡率分阶段设定医疗政策优先级,并构建国家层面模型,聚焦严重急诊疾病。模型设短期、中期、长期目标:短期将特定病种院内死亡率高于全国均值的地区降至全国均值;中期降至全国最低地区水平;长期对齐OECD国家平均或最低水平。用韩国国家急诊科信息系统数据分析急性心肌梗死、卒中与脓毒症:短期目标下可治疗死亡分别为191、249、546例,中期为749、958、1552例,长期为2606、1642、2619例,据此建议将更多医疗资源重新分配给脓毒症。

要点

  • 短期目标(病种院内死亡率高于全国均值的地区降至全国均值)下可治疗死亡:急性心肌梗死191例、卒中249例、脓毒症546例。
  • 中期目标(降至全国最低地区水平)下可治疗死亡:急性心肌梗死749例、卒中958例、脓毒症1552例。
  • 长期目标(对齐OECD国家平均或最低水平)下可治疗死亡:急性心肌梗死2606例、卒中1642例、脓毒症2619例。
  • 作者据模型结果建议将更多医疗资源重新分配给脓毒症而非急性心肌梗死或卒中。
  • 模型基于韩国国家急诊科信息系统数据,分析急性心肌梗死、卒中与脓毒症三类严重急诊疾病。

适用人群与场景

  • 国家层面严重急诊疾病人群,模型应用时分析韩国国家急诊科信息系统中的急性心肌梗死、卒中与脓毒症患者。

诊断标准与关键阈值

  • 短期目标:将特定疾病类别中院内死亡率超过全国均值的地区降至全国均值。
  • 中期目标:将特定疾病组院内死亡率降至全国最低地区的水平。
  • 长期目标:将院内死亡率对齐OECD国家中平均或最低的死亡率水平。

研究设计与关键结果

  • 研究构建国家层面可治疗死亡评估模型,设短期、中期、长期分阶段目标以降低死亡率并提升医疗效率。
  • 模型应用韩国国家急诊科信息系统数据,分析急性心肌梗死、卒中与脓毒症。
  • 达到短期目标时可治疗死亡:急性心肌梗死191例、卒中249例、脓毒症546例。
  • 达到中期目标时可治疗死亡:急性心肌梗死749例、卒中958例、脓毒症1552例。
  • 达到长期目标时可治疗死亡:急性心肌梗死2606例、卒中1642例、脓毒症2619例。
  • 作者据此建议将更多医疗资源重新分配给脓毒症而非急性心肌梗死或卒中。

证据类型、等级与局限

  • 证据类型:基于韩国国家急诊科信息系统数据的模型研究。
  • 局限:原文提及存在局限性,但摘要未具体列出。

对床旁实践的改变

  • 作者认为,可治疗死亡率可作为制定医疗政策的指标,分阶段方法为不同层面的政策制定提供参考。
  • 作者认为,模型为资源分配和国际死亡率比较提供基础,目标是达到全球可实现的死亡率水平。
  • 作者建议将更多医疗资源重新分配给脓毒症而非急性心肌梗死或卒中。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: The global provision of essential healthcare stands as a critical concern. Consequently, healthcare policies play a pivotal role in determining the allocation of resources. However, the optimal indicators for prioritizing such policies remain uncertain. This study proposes that employing the concept of treatable mortality in a stepwise manner could serve as a viable approach to setting healthcare policy priorities. Furthermore, it aims to demonstrate this concept through the application of real-world data.

METHODS: A model was developed to assess treatable mortality at a national level focusing on severe emergency conditions. We established stepwise targets, encompassing short-term, mid-term, and long-term goals to reduce mortality rates and enhance healthcare efficiency. The short-term target consists of directing attention to regions exhibiting in-hospital mortality rates surpassing the national average within a specific disease category and reducing them to the national average. The mid-term objective entails decreasing the in-hospital mortality rate of the specific disease group to match that of the region with the lowest rate nationwide. As for long-term target, it aligns the in-hospital mortality rate with that of OECD countries possessing average or lowest rates. The model was applied using data from South Korea's National Emergency Department Information System, specifically analyzing acute myocardial infarction (AMI), stroke, and sepsis.

RESULTS: Reaching the short-term target resulted in the treatable deaths for AMI numbered 191, for stroke 249, and for sepsis 546. Meeting the mid-term target led to treatable deaths for AMI at 749, for stroke at 958, and for sepsis at 1552. Finally, achieving the long-term target yielded the treatable deaths for AMI at 2606, for stroke at 1642, and for sepsis at 2619. Consequently, a reallocation of more healthcare resources to sepsis over AMI or stroke is recommended.

CONCLUSIONS: This study proposes the utilization of treatable mortality as a metric for establishing healthcare policies. The stepwise approach provides valuable insights for policymaking at various levels. Despite limitations, the model offers a foundation for resource allocation and international mortality rate comparisons, aiming for achievable rates worldwide.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Hyun JH, Park SH, Kim K, et al. How to determine the focus of emergent medical care in healthcare policy: Proposal of treatable death. Am J Emerg Med. 2024. PMID: 38838473. doi:10.1016/j.ajem.2024.05.025

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。